What is an Oncology Hospitalist?

0

doctor-medical-medicine-health-42273

Managing the care of cancer patients who need hospitalization calls for specialized resources and expertise, including familiarity with an array of cancer medications and their potential side effects.

When an adult cancer patient is admitted to Dana-Farber’s Inpatient Hospital, located within Brigham and Women’s Hospital, his or her care is managed by a team led by a medical oncology hospitalist.

Oncology hospitalists are a relatively new type of cancer physician. Based full-time in the hospital, they manage the day to day care of inpatients while closely coordinating with the primary oncologist.

These days much of cancer diagnosis and treatment occurs in outpatient settings and at home, as more medications can be given in oral form. Patients may need hospitalization if their disease worsens or they develop a treatment complication, or experience side effects of a standard or experimental medication.

Hospitalists work in multidisciplinary teams with nurses, physician assistants, pharmacists, nutritionists, social workers, and other specialists, including surgeons, radiologists, and palliative care experts. Because they’re based in the hospital, they’re well-positioned to coordinate tests, treatments, and transportation, while monitoring patients’ day-to-day progress.

The patient’s primary oncologist will continue to make visits and be involved with the oncology hospitalists in decisions related to their cancer treatment.

The Dana-Farber team, based in the Department of Oncology Hospital Medicine, includes Brett Glotzbecker, MD; Nancy Andrea, MD; Aymen Elfiky, MD; and Prashant Nageshwar, MD.

Edwin Alyea, MD, Dana-Farber’s physician leader of Inpatient Oncology and associate director of the Dana-Farber/Brigham and Women’s Cancer Center Adult Stem Cell Transplantation Program, heads the oncology hospitalist program.

“In addition to providing excellent care, oncology hospitalists focus on improving quality and efficiency as well as safety in the inpatient environment,” Alyea says.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.